473 related articles for article (PubMed ID: 26073983)
1. HLA-G: An Immune Checkpoint Molecule.
Carosella ED; Rouas-Freiss N; Tronik-Le Roux D; Moreau P; LeMaoult J
Adv Immunol; 2015; 127():33-144. PubMed ID: 26073983
[TBL] [Abstract][Full Text] [Related]
2. HLA-G 2012 conference: the 15-year milestone update.
Loustau M; Wiendl H; Ferrone S; Carosella ED
Tissue Antigens; 2013 Mar; 81(3):127-36. PubMed ID: 23347068
[TBL] [Abstract][Full Text] [Related]
3. The potential role of HLA-G polymorphism in maternal tolerance to the developing fetus.
Agrawal S; Pandey MK
J Hematother Stem Cell Res; 2003 Dec; 12(6):749-56. PubMed ID: 14977483
[TBL] [Abstract][Full Text] [Related]
4. HLA-G: A New Immune Checkpoint in Cancer?
Krijgsman D; Roelands J; Hendrickx W; Bedognetti D; Kuppen PJK
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630545
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs targeting the immunomodulatory HLA-G gene: a new survey searching for microRNAs with potential to regulate HLA-G.
Porto IO; Mendes-Junior CT; Felício LP; Georg RC; Moreau P; Donadi EA; Chies JA; Castelli EC
Mol Immunol; 2015 Jun; 65(2):230-41. PubMed ID: 25700346
[TBL] [Abstract][Full Text] [Related]
6. Tolerance versus immune response -- microRNAs as important elements in the regulation of the HLA-G gene expression.
Veit TD; Chies JA
Transpl Immunol; 2009 Mar; 20(4):229-31. PubMed ID: 19038339
[TBL] [Abstract][Full Text] [Related]
7. New insights into HLA-G mediated tolerance.
Amodio G; Sales de Albuquerque R; Gregori S
Tissue Antigens; 2014 Sep; 84(3):255-63. PubMed ID: 25132109
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Transcriptomic Analysis Reveals the Role of the Immune Checkpoint HLA-G Molecule in Cancers.
Xu HH; Gan J; Xu DP; Li L; Yan WH
Front Immunol; 2021; 12():614773. PubMed ID: 34276642
[TBL] [Abstract][Full Text] [Related]
9. The immunosuppressive molecule HLA-G and its clinical implications.
González A; Rebmann V; LeMaoult J; Horn PA; Carosella ED; Alegre E
Crit Rev Clin Lab Sci; 2012; 49(3):63-84. PubMed ID: 22537084
[TBL] [Abstract][Full Text] [Related]
10. HLA-G: An Important Mediator of Maternal-Fetal Immune-Tolerance.
Zhuang B; Shang J; Yao Y
Front Immunol; 2021; 12():744324. PubMed ID: 34777357
[TBL] [Abstract][Full Text] [Related]
11. Role of microRNAs on HLA-G expression in human tumors.
Seliger B
Hum Immunol; 2016 Sep; 77(9):760-3. PubMed ID: 27142884
[TBL] [Abstract][Full Text] [Related]
12. HLA-G: Too Much or Too Little? Role in Cancer and Autoimmune Disease.
Martín-Villa JM; Vaquero-Yuste C; Molina-Alejandre M; Juarez I; Suárez-Trujillo F; López-Nares A; Palacio-Gruber J; Barrera-Gutiérrez L; Fernández-Cruz E; Rodríguez-Sainz C; Arnaiz-Villena A
Front Immunol; 2022; 13():796054. PubMed ID: 35154112
[TBL] [Abstract][Full Text] [Related]
13. Roles of HLA-G/KIR2DL4 in Breast Cancer Immune Microenvironment.
Zheng G; Jia L; Yang AG
Front Immunol; 2022; 13():791975. PubMed ID: 35185887
[TBL] [Abstract][Full Text] [Related]
14. HLA-G and humanized mouse models as a novel therapeutic approach in transplantation.
Ajith A; Portik-Dobos V; Horuzsko DD; Kapoor R; Mulloy LL; Horuzsko A
Hum Immunol; 2020 Apr; 81(4):178-185. PubMed ID: 32093884
[TBL] [Abstract][Full Text] [Related]
15. Soluble monomers, dimers and HLA-G-expressing extracellular vesicles: the three dimensions of structural complexity to use HLA-G as a clinical biomarker.
Nardi Fda S; König L; Wagner B; Giebel B; Santos Manvailer LF; Rebmann V
HLA; 2016 Sep; 88(3):77-86. PubMed ID: 27440734
[TBL] [Abstract][Full Text] [Related]
16. In vivo evidence that secretion of HLA-G by immunogenic tumor cells allows their evasion from immunosurveillance.
Loumagne L; Baudhuin J; Favier B; Montespan F; Carosella ED; Rouas-Freiss N
Int J Cancer; 2014 Nov; 135(9):2107-17. PubMed ID: 24623585
[TBL] [Abstract][Full Text] [Related]
17. Galectin-1 influences trophoblast immune evasion and emerges as a predictive factor for the outcome of pregnancy.
Tirado-González I; Freitag N; Barrientos G; Shaikly V; Nagaeva O; Strand M; Kjellberg L; Klapp BF; Mincheva-Nilsson L; Cohen M; Blois SM
Mol Hum Reprod; 2013 Jan; 19(1):43-53. PubMed ID: 23002109
[TBL] [Abstract][Full Text] [Related]
18. Molecular pathways: human leukocyte antigen G (HLA-G).
Curigliano G; Criscitiello C; Gelao L; Goldhirsch A
Clin Cancer Res; 2013 Oct; 19(20):5564-71. PubMed ID: 23897901
[TBL] [Abstract][Full Text] [Related]
19. New Developments in HLA-G in Cardiac Transplantation.
Lazarte J; Tumiati LC; Rao V; Delgado DH
Hum Immunol; 2016 Sep; 77(9):740-5. PubMed ID: 26707934
[TBL] [Abstract][Full Text] [Related]
20. HLA-G and immune evasion in cancer cells.
Sheu J; Shih IeM
J Formos Med Assoc; 2010 Apr; 109(4):248-57. PubMed ID: 20434034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
